ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
Miami, (Address of principal executive offices) |
(Zip Code) |
Title of each class: |
Trading Symbol(s) |
Name of each exchange on which registered: | ||
and one-half of one redeemable Warrant |
||||
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
☒ |
Smaller reporting company |
|||||
Emerging growth company |
Item 15. |
Exhibit and Financial Statement Schedules. |
Page |
||||
F-1 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-7 |
||||
F-8 |
December 31, |
||||||||
2022 |
2021 |
|||||||
(restated) |
(restated) |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid assets |
||||||||
Total Current Assets |
||||||||
Prepaid assets |
||||||||
Cash Held in Trust Account |
||||||||
TOTAL ASSETS |
$ |
$ |
||||||
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Note payable Sponsor |
||||||||
Income taxes – payable |
||||||||
Franchise tax payable |
||||||||
Working capital loans |
||||||||
Advances – related party |
||||||||
Total Current Liabilities |
||||||||
Deferred underwriter fee payable |
||||||||
TOTAL LIABILITIES |
||||||||
Commitments and Contingencies |
||||||||
Class A common stock subject to possible redemption, $ |
||||||||
Stockholders’ Deficit |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ issued and outstanding, excluding |
||||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Stockholders’ Deficit |
( |
) | ( |
) | ||||
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
$ |
$ |
||||||
For the Year ended December 31, |
||||||||
2022 |
2021 |
|||||||
(restated) |
(restated) |
|||||||
Formation and operating costs |
$ | $ | ||||||
Legal investigations costs |
||||||||
Franchise tax expense |
||||||||
Loss from operating costs |
( |
) |
( |
) | ||||
Other income and expenses: |
||||||||
Interest earned on cash held in Trust Account |
||||||||
Loss before income taxes |
( |
) | ( |
) | ||||
Income tax expense |
||||||||
Net loss |
$ |
( |
) |
$ |
( |
) | ||
Weighted average shares outstanding of Class A common stock |
||||||||
Basic and diluted net loss per Class A common stock |
$ |
( |
) |
$ |
( |
) | ||
Weighted average shares outstanding of Class B common stock |
||||||||
Basic and diluted net loss per Class B common stock |
$ |
( |
) |
$ |
( |
) | ||
Class A Common Stock |
Class B Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – December 31, 2021 (restated) |
$ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||
Net loss |
( |
) | ( |
) | ||||||||||||||||||||||||
Remeasurement of Class A common stock to redemption value |
( |
) | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – December 31, 2022 (restated) |
$ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Common Stock |
Class B Common Stock |
Additional Paid-In |
Accumulated |
Total Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance – December 31, 2020 |
||||||||||||||||||||||||||||
Issuance of Class B common stock to sponsor (1)(2) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Class A common stock accretion to redemption value |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Issuance of Class A common stock to investor, net of offering costs |
— | — | — | |||||||||||||||||||||||||
Issuance of Class A common stock to representative |
( |
) | ||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – December 31, 2021 (restated) |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | The shares and the associated amounts have been retroactively restated to reflect the |
(2) | On September 2, 2021, the Sponsor surrendered an aggregate of |
For the Year end December 31, |
||||||||
2022 |
2021 |
|||||||
(restated) |
||||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ |
( |
) |
$ |
( |
) | ||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Interest earned on cash and marketable securities held in Trust Account |
( |
) |
( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Accrued expenses |
||||||||
Income taxes payable |
||||||||
Prepaid insurance |
( |
) | ||||||
Franchise tax payable |
||||||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
Cash flows from investing activities: |
||||||||
Investment of cash in Trust Account |
( |
) |
( |
) | ||||
Cash withdrawn from Trust Account for redemptions |
— |
|||||||
Net cash used in investing activities |
( |
) |
( |
) | ||||
Cash flows from financing activities: |
||||||||
Proceeds from sale of Units |
||||||||
Proceeds from sale of private placement warrants |
||||||||
Proceeds from Sponsor note |
||||||||
Repayment of Sponsor note |
( |
) | ||||||
Due from Sponsor |
( |
) | ||||||
Payment of due from Sponsor |
||||||||
Payment of offering costs |
( |
) | ||||||
Proceeds from working capital loan |
||||||||
Proceeds from advances – related party |
||||||||
Redemption of shares |
( |
) |
— |
|||||
Proceeds from issuance of Class B common stock to Sponsor |
||||||||
Net cash provided by financing activities |
||||||||
Net change in cash |
( |
) |
||||||
Cash at beginning of period |
||||||||
Cash at end of period |
$ |
$ |
||||||
Non-cash investing and financing activities: |
||||||||
Deferred underwriting fee payable |
$ |
$ |
||||||
Remeasurement of Class A common stock |
$ |
$ |
As previously reported |
Adjustments |
As restated |
||||||||||
Balance sheet as of December 31, 2022 |
||||||||||||
Accrued expenses |
||||||||||||
Income tax payable |
— | |||||||||||
Related party advance |
||||||||||||
Total current liabilities |
||||||||||||
Total liabilities |
||||||||||||
Accumulated deficit |
( |
) |
( |
) | ( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) | ( |
) | ||||||
Statement of Operations for the year ended December 31, 2022 |
||||||||||||
Legal investigations costs |
— | |||||||||||
Formation and operating costs |
( |
) |
||||||||||
Loss from operation costs |
( |
) |
( |
) | ( |
) | ||||||
Loss before income taxes |
( |
) |
( |
) | ( |
) | ||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) |
( |
) | ||||||
Statement of Changes in Stockholders’ Deficit for the year ended December 31, 2022 |
||||||||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||
Total accumulated deficit |
( |
) |
( |
) | ( |
) | ||||||
Total stockholders’ deficit |
( |
) |
( |
) | ( |
) | ||||||
Statement of Cash Flows for the year ended December 31, 2022 |
As previously reported |
Adjustments |
As restated |
||||||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||
Accrued expenses |
||||||||||||
Related party advance |
||||||||||||
Net cash provided by operating activities |
As previously reported |
Adjustments |
As restated |
||||||||||
Balance sheet as of September 30, 2022 |
||||||||||||
Accrued expenses |
( |
) | ||||||||||
Income tax payable |
||||||||||||
Related party advance |
— |
|||||||||||
Total current liabilities |
||||||||||||
Total liabilities |
||||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Operations for the three months ended September 30, |
||||||||||||
Legal investigations costs |
— |
|||||||||||
Formation and operating costs |
( |
) |
||||||||||
Loss from operation costs |
( |
) |
( |
) |
( |
) | ||||||
Loss before income taxes |
( |
) |
( |
) |
( |
) | ||||||
Income tax expense |
( |
) |
( |
) |
( |
) | ||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) |
( |
) | ||||||
Statement of Operations for the nine months ended September 30, 2022 |
||||||||||||
Legal investigations costs |
— |
|||||||||||
Formation and operating costs |
( |
) |
||||||||||
Loss from operation costs |
( |
) |
( |
) |
( |
) | ||||||
Loss before income taxes |
( |
) |
( |
) |
( |
) | ||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) |
( |
) | ||||||
Statement of Changes in Stockholders’ Deficit for nine months ended |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Total accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total stockholders’ deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Cash Flows for the nine months ended September 30, 2022 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Accrued expenses |
( |
) |
||||||||||
Income tax payable |
— |
|||||||||||
Net cash provided by operations |
( |
) |
( |
) |
( |
) | ||||||
Related party advance |
— |
|||||||||||
Net cash provided by financing activities |
As previously reported |
Adjustments |
As restated |
||||||||||
Balance sheet as of June 30, 2022 |
||||||||||||
Accrued expenses |
||||||||||||
Income tax payable |
||||||||||||
Related party advance |
— | |||||||||||
Total current liabilities |
||||||||||||
Total liabilities |
||||||||||||
Class A common stock subject to possible redemption |
||||||||||||
Accumulated deficit |
( |
) |
( |
) | ( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) | ( |
) | ||||||
Statement of Operations for the three months ended June 30, 2022 |
||||||||||||
Legal investigations costs |
— | |||||||||||
Formation and operating costs |
( |
) |
||||||||||
Loss from operation costs |
( |
) |
( |
) | ||||||||
Loss before income taxes |
( |
) |
( |
) | ||||||||
Income tax expense |
( |
) |
( |
) | ||||||||
Net loss |
( |
) |
( |
) | ||||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) | ||||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) | ||||||||
Statement of Operations for the six months ended June 30, 2022 |
||||||||||||
Legal investigations costs |
— |
|||||||||||
Formation and operating costs |
( |
) |
||||||||||
Franchise tax |
— |
|||||||||||
Loss from operation costs |
( |
) |
( |
) | ( |
) | ||||||
Loss before income taxes |
( |
) |
( |
) | ( |
) | ||||||
Income tax expense |
( |
) |
( |
) | ||||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) | ||||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) | ||||||||
Statement of Changes in Stockholders’ Deficit for six months ended June 30, |
||||||||||||
Net loss |
( |
) |
( |
) | ( |
) | ||||||
Remeasurement of Class A common stock to redemption value |
( |
) |
( |
) |
( |
) | ||||||
Total accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total stockholders’ deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Cash Flows for the six months ended June 30, 2022 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Accrued expenses |
( |
) | ||||||||||
Income tax payable |
— |
|||||||||||
Net cash provided by operations |
( |
) |
( |
) |
( |
) | ||||||
Related party advance |
— |
|||||||||||
Net cash provided by financing activities |
As previously reported |
Adjustments |
As restated |
||||||||||
Balance sheet as of March 31, 2022 |
||||||||||||
Accrued expenses |
||||||||||||
Related party advance |
— |
|||||||||||
Total current liabilities |
||||||||||||
Total liabilities |
||||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Operations for the three months ended March 31, 2022 |
||||||||||||
Legal investigations costs |
— |
|||||||||||
Formation and operating costs |
( |
) |
||||||||||
Loss from operation costs |
( |
) |
( |
) |
( |
) | ||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) |
( |
) | ||||||
Statement of Changes in Stockholders’ Deficit for three months ended March 31, 2022 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Total accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total stockholders’ deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Cash Flows for the three months ended March 31, 2022 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Accrued expenses |
||||||||||||
Net cash provided by operations |
( |
) |
( |
) |
( |
) | ||||||
Related party advance |
— |
|||||||||||
Net cash provided by financing activities |
As previously reported |
Adjustments |
As restated |
||||||||||
Balance sheet as of December 31, 2021 |
||||||||||||
Accrued expenses |
||||||||||||
Related party advance |
— |
|||||||||||
Total current liabilities |
||||||||||||
Total liabilities |
||||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Operations for the year ended December 31, 2021 |
||||||||||||
Formation and operating costs |
||||||||||||
Franchise tax |
— |
|||||||||||
Loss from operation costs |
( |
) |
( |
) |
( |
) | ||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class A common stock |
( |
) |
( |
) |
( |
) | ||||||
Basic and diluted net loss per Class B common stock |
( |
) |
( |
) |
( |
) | ||||||
Statement of Changes in Stockholders’ Deficit for the year ended December 31, 2021 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Total accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total stockholders’ deficit |
( |
) |
( |
) |
( |
) | ||||||
Statement of Cash Flows for the year ended December 31, 2021 |
||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||
Accrued expenses |
||||||||||||
Net cash provided by operations |
( |
) |
( |
) |
( |
) | ||||||
Related party advance |
— |
|||||||||||
Net cash provided by financing activities |
• |
in whole and not in part; |
• | at a price of $ |
• | at any time after the warrants become exercisable; |
• | upon not less than |
• | if, and only if, the reported last sale price of the Class A common stock equals or exceeds $ share (as adjusted for stock splits, stock dividends, reorganizations, and recapitalizations) for any |
• | if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants. |
December 31, 2022 |
December 31, 2021 |
|||||||
Deferred tax assets: |
||||||||
Net operating losses |
$ | $ | ||||||
Start-up costs |
||||||||
Total deferred tax assets |
||||||||
Valuation Allowance |
( |
) | ( |
) | ||||
Deferred tax asset, net of allowance |
$ | $ | ||||||
For the Year Ended December 31, 2022 |
For the Year Ended December 31, 2021 |
|||||||
Federal |
||||||||
Current |
$ |
( |
) | $ |
( |
) | ||
Deferred |
||||||||
State and local |
||||||||
Current |
( |
) | ( |
) | ||||
Deferred |
||||||||
Change in valuation allowance |
||||||||
Income tax provision |
$ |
$ |
||||||
For the Year Ended December 31, 2022 |
For the Year Ended December 31, 2021 |
|||||||
Federal income taxes at |
% | % | ||||||
State tax, net of Federal benefit |
% | % | ||||||
Change in valuation allowance |
( |
)% | ( |
)% | ||||
Provision for income tax |
( |
)% | ||||||
As Restated |
||||||||||||
September 30, 2022 |
June 30, 2022 |
March 31, 2022 |
||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash |
$ |
$ |
$ |
|||||||||
Prepaid assets |
||||||||||||
Total Current Assets |
||||||||||||
Prepaid assets |
||||||||||||
Investments held in Trust Account |
||||||||||||
TOTAL ASSETS |
$ |
$ |
$ |
|||||||||
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
||||||||||||
Current liabilities |
||||||||||||
Accrued expenses |
$ |
$ |
$ |
|||||||||
Note payable – Sponsor |
||||||||||||
Income taxes payable |
||||||||||||
Franchise tax payable |
||||||||||||
Working capital loans |
||||||||||||
Advances – related parties |
||||||||||||
Total Current Liabilities |
||||||||||||
Deferred underwriting fee payable |
||||||||||||
TOTAL LIABILITIES |
||||||||||||
Commitments and Contingencies |
||||||||||||
Class A common stock subject to possible redemption, $ par value, per share) |
||||||||||||
Stockholders’ Deficit |
||||||||||||
Preferred stock, $ par value; |
||||||||||||
Class A common stock, $ par value; |
||||||||||||
Class B common stock, $ par value; |
||||||||||||
Additional paid-in capital |
||||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Stockholders’ Deficit |
( |
) |
( |
) |
( |
) | ||||||
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT |
$ |
$ |
$ |
|||||||||
As Restated |
||||||||||||||||||||
Three Months Ended March 31, 2022 |
Three Months Ended June 30, 2022 |
Six Months Ended June 30, 2022 |
Three Months Ended September 30, 2022 |
Nine Months Ended September 30, 2022 |
||||||||||||||||
Formation and operating costs |
||||||||||||||||||||
Legal investigations costs |
||||||||||||||||||||
Franchise tax expense |
||||||||||||||||||||
Loss from operating costs |
||||||||||||||||||||
Other income and expenses: |
||||||||||||||||||||
Interest earned on investments held in Trust Account |
||||||||||||||||||||
Loss before income taxes |
( |
) |
( |
) |
( |
) |
( |
) |
) | |||||||||||
Income tax expense |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding of Class A common stock |
||||||||||||||||||||
Weighted average shares outstanding of Class B common stock |
||||||||||||||||||||
Basic and diluted net loss per Class A common stock |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||
Basic and diluted net loss per Class B common stock |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||
As Restated |
||||||||||||||||||||||||||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Balance – March 31, 2022 |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
( |
) |
( |
) | ||||||||||||||||||||||||
Remeasurement of Class A common stock to redemption value |
( |
) |
( |
) | ||||||||||||||||||||||||
Balance – June 30, 2022 |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Remeasurement of Class A common stock to redemption value |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Contribution |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Balance – September 30, 2022 |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Remeasurement of Class A common stock to redemption value |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Balance – December 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
As Restated |
||||||||||||
Three Months Ended March 31, 2022 |
Six Months Ended June 30, 2022 |
Nine Months Ended September 30, 2022 |
||||||||||
Cash flows from operating activities: |
||||||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Interest earned on cash and marketable securities held in the Trust Account |
( |
) |
( |
) |
( |
) | ||||||
Changes in assets and liabilities: |
||||||||||||
Accrued expenses |
||||||||||||
Income taxes payable |
— |
|||||||||||
Prepaid insurance |
||||||||||||
Franchise tax payable |
||||||||||||
Net cash used in operating activities |
( |
) |
( |
) |
( |
) | ||||||
Cash flows from investing activities: |
||||||||||||
Cash deposited into Trust Account |
— |
— |
( |
) | ||||||||
Net cash used in investing activities |
— |
— |
( |
) | ||||||||
Cash flows from financing activities: |
||||||||||||
Proceeds from working capital loan |
||||||||||||
Proceeds from advances – related parties |
||||||||||||
Proceeds from Sponsor note |
— |
— |
||||||||||
Net cash provided by financing activities |
||||||||||||
Net change in cash |
( |
) |
( |
) |
( |
) | ||||||
Cash at beginning of period |
||||||||||||
Cash at end of period |
$ |
$ |
$ |
|||||||||
Non-cash investing and financing activities: |
||||||||||||
Remeasurement of Class A common stock |
$ |
$ |
$ |
|||||||||
EXHIBIT INDEX
* | Filed herewith. |
** | Furnished herewith. |
+ | Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). DWAC agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request. |
(1) | Incorporated herein by reference to the Company’s Registration Statement on Form S-1 (File No. 333-256472), filed with the SEC on May 26, 2021. |
(2) | Incorporated herein by reference to Amendment No. 2 to the Company’s Registration Statement on Form S-1/A (File No. 333-256472), filed with the SEC on July 26, 2021. |
(3) | Incorporated herein by reference to Amendment No. 4 to the Company’s Registration Statement on Form S-1/A (File No. 333-256472), filed with the SEC on August 20, 2021. |
(4) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on September 9, 2021. |
(5) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on October 26, 2021. |
(6) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on December 6, 2021. |
(7) | Incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on April 13, 2022. |
(8) | Incorporated by reference to the Company’s Registration Statement on Form S-4, filed with the SEC on May 16, 2022. |
(9) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on November 30, 2022. |
(10) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on September 9, 2022. |
(11) | Incorporated herein by reference to the Company’s Current Report on Form 8-K, filed with the SEC on April 13, 2023. |
(12) | Incorporated herein by reference to the Company’s Annual Report on Form 10-K, filed with the SEC on April 26, 2023. |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
DATE: January 9, 2024 |
DIGITAL WORLD ACQUISITION CORP. | |||||
By: | /s/ Eric Swider | |||||
Name: | Eric Swider | |||||
Title: | Chief Executive Officer and Director (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name |
Position |
Date | ||
/s/ Eric Swider Eric Swider |
Chief Executive Officer (Principal Executive Officer) |
January 9, 2024 | ||
/s/ Katherine Chiles Katherine Chiles |
Chief Financial Officer (Principal Financial and Accounting Officer) |
January 9, 2024 | ||
/s/ Alexander Cano Alexander Cano |
President and Secretary |
January 9, 2024 | ||
/s/ Frank Andrews Frank Andrews |
Non-Executive Chairman and Director |
January 9, 2024 | ||
/s/ Edward Preble Edward Preble |
Director |
January 9, 2024 | ||
/s/ Jeffrey Smith Jeffrey Smith |
Director |
January 9, 2024 |